We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

India Stays Exclusive Marketing Rights For Eli Lilly's Cialis

Law360 (September 9, 2004, 12:00 AM EDT) -- The Indian patent office has stayed the exclusive marketing rights (EMR) for Eli Lilly’s anti-impotence drug Cialis, raising fresh doubts about the system that was meant as a temporary measure to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.